I agree that they needed the additional study (which is underway, I believe). However, I think it is important to realize the cost of another study of that siz

I agree that they needed the additional study (which is underway, I believe). However, I think it is important to realize the cost of another study of that size is very expensive and often small vaccine companies can't afford unplanned major studies without going back to the financial drawing board.